A Exploratory Study on Untreated Follicular Lymphoma With Orelabrutinib, Tafasitamab, and Lenalidomide
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Follicular Lymphoma
Related studies linked through entity extraction aliases.
Mosunetuzumab and Zeprumetostat in Treating Patients With Follicular Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Zanubrutinib, Obinutuzumab Combined With Lenalidomide (ZGR) for the Treatment of Untreated Follicular Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Study of Tazemetostat in Adults With Follicular Lymphoma Previously Treated With at Least Two Therapies
- Status
- WITHDRAWN
- Phase
- N/A
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
- Status
- RECRUITING
- Phase
- PHASE1
Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Phase 2, Multicenter, Open-Label Trial to Evaluate Efficacy and Safety of Subcutaneous (SC) Mosunetuzumab in Previously Untreated Low Tumor Burden Follicular Lymphoma (LTB-FL).
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Evaluation of the Efficacy and Safety of TQB2825 Injection Compared to Immunotherapy in the Treatment of Recurrent/Refractory Follicular Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1
Odronextamab in Low Tumor Volume Advanced FL
- Status
- RECRUITING
- Phase
- PHASE2
Fixed-Duration Zanubrutinib, Bendamustine, and Obinutuzumab (ZBG) in Treatment-Naïve Advanced Stage Follicular Lymphoma
- Status
- RECRUITING
- Phase
- NA
A Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas
- Status
- RECRUITING
- Phase
- PHASE3
JWCAR239 in Patients With B Cell Non-Hodgkin Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Evaluation of Skin Tests in Biotherapy Allergies
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Zanubrutinib Plus GCVP (Obinutuzumab, Cyclophosphamide, Vindesine, Prednisolone) in Previously Untreated Follicular Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
- Status
- RECRUITING
- Phase
- PHASE3
Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
- Status
- RECRUITING
- Phase
- NA
CD70-targeted immunoPET Imaging of Malignant Cancers
- Status
- RECRUITING
- Phase
- PHASE2
Real-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma
- Status
- RECRUITING
- Phase
- N/A
Axicabtagene Ciloleucel Injection in Patients With Relapsed/Refractory Follicular Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2